In a previous post, we wrote about how publishing a manuscript can - for a recently founded small company - be an extremely helpful exercise in any number of ways beyond simply adding a line or two on a founder’s CV. What about for a more developed, more mature enterprise - are publications still important?

Typically, if you have progressed to an advanced degree in the sciences or engineering, or many other fields, you either have planned to - or already have undertaken - the writing of a manuscript for publication. In academia, it is abundantly clear that in order to advance your career…

Launching a biotech startup is no small feat. Doing it without the backing, or assistance, of an experienced venture capital group or a business incubator also means that you will have to wear many more hats than you probably even expected...

On the topic of writing, many leaders of small biotech companies have told me that two important goals are raising money and building awareness. When it comes to the former, applying some simple project management techniques to your grant submission process can greatly improve the quality of the application…

Startups are a great wellspring of innovation and new products or therapeutics. But guess what? Your startup is a business! Now, if you already have in hand, or are developing, a product or therapeutic for which the world will automatically…

You have a good idea and some hot data. You started a company. You managed to get some seed money. More research funds are always helpful. You don’t want to cede any additional control of your company. How about small business support from the National Institutes of Health…

Being optimistic is about being hopeful and having confidence in the successful outcome of any endeavor. When you submit a manuscript or grant, surely you are filled with a sense of relief, but where does optimism weigh into the equation?

Over the past 10 years, data science and machine learning have been applied to almost all industries and academic fields. From the general idea of making data-driven decisions and predictions, we have stepped into an era of using models in daily operations for virtually everything.

Now that you have completed your specific aims, significance and innovation, and the bulk of your research strategy and have sent those files for numerous rounds of pre-peer review by your trusted colleagues and mentors, it is time to focus on some smaller, yet still very important details.

In the previous post, we described how to write an effective significance and innovation section, focused on defining the problem and providing a high-level overview of your proposed solution. In this post, we’ll outline the approach, wherein you’ll expand upon the solution and illustrate exactly how you plan to conduct the research.

The significance and innovation section is a recent (within the last 10 years) addition to the NIH and most other foundation grant applications. It is a place for you to showcase WHY the work should be done – WHY there is a significant need for your study, and HOW the work is different from everyone else’s approach. What makes it groundbreaking, original research, work that will advance our scientific knowledge?

So you’re thinking of writing a grant to fund your lab or fund your start up...Where do you start?

First, if you already have a target award in mind (for example: SBIR, NIH K-01, K-08, R-01, NSF, or American Heart Association), great! If not, you will need to research the appropriate funding opportunities, including those offered by governmental organizations or private foundations.

You’ve probably heard the phrase “What Color is your Parachute?” – taken from a book to guide you toward your career destiny by understanding who you are and what you value in life. I have always had a fascination with science – a need to understand the physiological mechanisms of the human body, and particularly, how to apply this knowledge to treat disease.

JetPub Scientific Communications is a proud sponsor of the 20th Annual Boston Angiogenesis meeting to be held on November 2, 2018.

This meeting was started 20 yers ago by Dr. Patricia D'Amore. Each year, this well-established annual one-day meeting has brought together physician scientists, leaders, young faculty, postdocs, graduate students, medical students as well as representatives from industry to present, discuss, and network around their common interest in angiogenesis.

What started as a passion project in the summer of 2015, has grown into a full-time business venture. Just about 3 years later, we have expanded our capabilities, our network of expert advisory board members, rebuilt our website, and are ready to take on the world one paper, grant, and blog post at a time!